
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $637.2M | -- | -- | $1.07 | -- |
08/01/2025 | Q2 | $617.9M | -- | -- | $1.02 | -- |
05/08/2025 | Q1 | $610.7M | $612.1M | -$0.11 | $0.96 | -$1.07 |
02/20/2025 | Q4 | $612.4M | $614.5M | -$0.08 | $0.97 | -$1.05 |
11/07/2024 | Q3 | $602.1M | $608.8M | -$0.09 | $0.92 | -$1.01 |
08/01/2024 | Q2 | $586.6M | $592.9M | -$0.16 | $0.88 | -$1.04 |
05/07/2024 | Q1 | $578.2M | $584.2M | -$0.31 | $0.80 | -$1.11 |
02/20/2024 | Q4 | $570.4M | $571.3M | -$0.50 | $0.82 | -$1.32 |
11/06/2023 | Q3 | -- | -- | -$0.45 | $0.75 | -$1.20 |
08/07/2023 | Q2 | -- | -- | -$0.23 | $0.75 | -$0.98 |
05/09/2023 | Q1 | -- | -- | -$0.57 | $0.70 | -$1.27 |
02/15/2023 | Q4 | -- | -- | -$2.97 | $0.59 | -$3.56 |
11/09/2022 | Q3 | -- | -- | -$2.98 | $0.51 | -$3.49 |
08/02/2022 | Q2 | -- | -- | -$1.68 | $0.40 | -$2.08 |
05/09/2022 | Q1 | -- | -- | -$1.60 | $0.34 | -$1.94 |
02/22/2022 | Q4 | -- | -- | -$1.27 | $0.37 | -$1.64 |
11/09/2021 | Q3 | -- | -- | -$1.60 | $0.33 | -$1.93 |
08/03/2021 | Q2 | -- | -- | -$1.22 | $0.28 | -$1.50 |
05/04/2021 | Q1 | -- | -- | -$0.00 | $0.25 | -$0.25 |
02/16/2021 | Q4 | -- | -- | -$0.02 | $0.27 | -$0.29 |
11/09/2020 | Q3 | -- | -- | -$0.24 | $0.24 | -$0.48 |
08/03/2020 | Q2 | -- | -- | $0.01 | $0.20 | -$0.19 |
05/06/2020 | Q1 | -- | -- | -$0.70 | $0.18 | -$0.88 |
02/10/2020 | Q4 | -- | -- | -$0.30 | $0.21 | -$0.51 |
11/04/2019 | Q3 | -- | -- | -$0.15 | $0.19 | -$0.34 |
08/05/2019 | Q2 | -- | -- | $0.21 | $0.16 | $0.05 |
05/06/2019 | Q1 | -- | -- | $0.17 | $0.15 | $0.02 |
02/11/2019 | Q4 | -- | -- | $0.23 | $0.18 | $0.05 |
11/05/2018 | Q3 | -- | -- | $0.19 | $0.16 | $0.03 |
08/06/2018 | Q2 | -- | -- | $0.19 | $0.15 | $0.04 |
05/09/2018 | Q1 | -- | -- | $0.16 | $0.12 | $0.04 |
02/12/2018 | Q4 | -- | -- | $0.07 | $0.06 | $0.01 |
11/08/2017 | Q3 | -- | -- | $0.06 | $0.04 | $0.02 |
08/02/2017 | Q2 | -- | -- | $0.04 | $0.03 | $0.01 |
04/25/2017 | Q1 | -- | -- | $0.03 | $0.02 | $0.01 |
02/13/2017 | Q4 | -- | -- | -- | -- | -- |
10/25/2016 | Q3 | -- | -- | -- | -- | -- |
08/03/2016 | Q2 | -- | -- | -- | -- | -- |
04/27/2016 | Q1 | -- | -- | -- | -- | -- |
02/04/2016 | Q4 | -- | -- | -- | -- | -- |
11/02/2015 | Q3 | -- | -- | -- | -- | -- |
RingCentral reported $612.1M worth of top line sales in its most recent quarter.
RingCentral announced earnings per share of -$0.11 which represents a miss of analyst forecast a $0.96 per share.
RingCentral reported $431.6M that represents $4.74 per share over the last quarter.
RingCentral's earnings are forecast to grow from -$0.63 per share to $3.69 per share next year representing an increase of --.
RingCentral's next earnings date is August 1, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.